phenoxodiol
Small moleculeexperimental
Clinical trial activity
7 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
4
Phase 3
1
Phase 4
0
Earliest trial started Aug 1, 2001 (NCT00022295)
Timeline
Indications
Mechanism of action
- Caspase-8INHIBITOR
CASP8 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
Oc1ccc(C2=Cc3ccc(O)cc3OC2)cc1- Mol. weight
- 240.26 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1957038 ↗
Also known as
- 2h-1-benzopyran-7-0,1,3-(4-hydroxyphenyl)
- 3-(4-hydroxyphenyl)-2h-chromen-7-ol
- 3-(4-hydroxyphenyl)-2h-chromen-7-ol
- 7-hydroxy-3-hydroxyphenyl-1h-benzopyran
- dehydroequol
- dehydroequol
- haginin e
- haginin e
- idronoxil
- idronoxil
- idronoxil
- idronoxil
- nv-06
- nv-06
- phenoxodiol
- phenoxodiol
- phenoxodiol
- phenoxodiol
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03041285 | Phase 1 | Apr 30, 2017 | Northern Sydney Local Health District, University of Sydney |
| NCT02941523 | Phase 1/Phase 2 (Phase 2) | Mar 3, 2017 | Noxopharm Limited |
| NCT00557037 | Phase 2 | Nov 1, 2007 | MEI Pharma, Yale University |
| NCT00382811 | Phase 3 | Oct 1, 2006 | MEI Pharma |
| NCT00303888 | Phase 1 | May 1, 2006 | National Cancer Institute (NCI), Yale University |
| NCT00091377 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2004 | Kazia Therapeutics Limited, MEI Pharma |
| NCT00022295 | Phase 1 | Aug 1, 2001 | Kazia Therapeutics Limited, MEI Pharma |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MEI Pharma | For profit | 4 | 3 | 3 | 2001 |
| Kazia Therapeutics Limited | For profit | 2 | 1 | 2 | 2001 |
| Yale University | Academic/Hospital | 2 | 1 | 2 | 2006 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2006 |
| Northern Sydney Local Health District | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Noxopharm Limited | For profit | 1 | 1 | 1 | 2017 |
| University of Sydney | Academic/Hospital | 1 | 1 | 1 | 2017 |
7 organizations
Page 1 / 1